Apogee Therapeutics, Inc. APGE Market capitalization

Market capitalization at other companies

Eli LillyLLY

$1.07T+53.1%

Regeneron PharmaceuticalsREGN

$65.37B+15.9%

Nektar TherapeuticsNKTR

$2.06B+1,531%

AbbVieABBV

$444.6B+35.6%

AnaptysBio, Inc.ANAB

$1.59B+180%

Avalo TherapeuticsAVTX

$971.41M+1,712%

FAQ

What is Apogee Therapeutics, Inc.'s market capitalization?

Apogee Therapeutics, Inc. (APGE) reported market capitalization of $6.28B in Q1 2026.

How has Apogee Therapeutics, Inc.'s market capitalization changed year-over-year?

Apogee Therapeutics, Inc.'s market capitalization increased by 189.3% year-over-year, from $2.17B to $6.28B.

What is the long-term trend for Apogee Therapeutics, Inc.'s market capitalization?

Over 2 years (2023 to 2025), Apogee Therapeutics, Inc.'s market capitalization has grown at a 96.1% compound annual growth rate (CAGR), from $1.34B to $5.16B.

What does market capitalization mean?

The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.